These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…
July 3, 2017 - 8 minutes
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…
Targovax has raised €21M (NOK200M) in a private placement, which the biotech will use to…
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO…
This week, we leave Belgium and keep traveling north to Oslo, where snow is starting…